3 Biotech Stocks to Be Thankful for This Year
Anyone who has been holding onto shares of Loxo Oncology Inc. (NASDAQ: LOXO), Nektar Therapeutics (NASDAQ: NKTR), or Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) will have plenty to say when it's their turn to share at the dinner table this Thanksgiving.
Surprisingly positive trial results for experimental cancer therapies helped shares of all three of these biotechs soar in 2017. Here's a closer look at what helped these stocks generate massive returns this year.
Image source: Getty Images.
Source: Fool.com
Nektar Therapeutics Stock
€1.52
9.860%
Currently there is a rather positive sentiment for Nektar Therapeutics with 3 Buy predictions and 1 Sell predictions.
With a target price of 3 € there is a hugely positive potential of 97.11% for Nektar Therapeutics compared to the current price of 1.52 €.
